Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Date:2/20/2008

102,608 101,892 102,273 101,761

Effect of dilutive securities:

Conversion of CODES 14,357 - 14,357 -

Dilutive stock options 409 - 409 -

Diluted weighted average common

shares outstanding 117,374 101,892 117,039 101,761

Diluted earnings per share - Adjusted

Diluted earnings per share -

Adjusted $0.35 $0.25 $1.37 $1.02

Basic weighted average common

shares outstanding 102,608 101,892 102,273 101,761

Effect of dilutive securities:

Conversion of CODES 14,357 14,357 14,357 14,357

Dilutive stock options 409 222 409 234

Diluted weighted average common

shares outstanding 117,374 116,471 117,039 116,352

The following table presents a reconciliation of reported net income for the three and twelve months ended December 31, 2007 and 2006 to adjusted EBITDA:

Table 5

Watson Pharmaceuticals, Inc.

Adjusted EBITDA Reconciliation Table

(Unaudited; in millions)

Three Months Twelve Months

Ended December 31, Ended December 31,

2007 2006 2007 2006

GAAP net income (loss) $38.4 $(489.0) $141.0 $(445.0)

Plus:

Interest expense 9.0 11.6 44.5 22.1

Interest income (2.2) (5.6) (8.9) (28.4)

Provision for income

taxes 21.4 7.8 83.2 34.1

Depreciation 20.2 17.6 77.2 54.6

Amortization 44.2
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and ... at the liquid/air interface. The NeedleProbes’ cylindrical geometry enables ... rate and viscosity - all in a single force distance ... ... 2009 -- New, constant diameter NeedleProbes are enabling ...
(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ... collaboration with The Scripps Research Institute ("Scripps") by ... the genome of Dyadic,s patented and proprietary C1 ... of the successful relationship between the two organizations ... Scripps to annotate the C1 genome for the ...
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
Breaking Biology Technology:New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... Qian Gao, Kris Simonyi, and Claudia Suen, Bio-Rad Laboratories, Inc.,2000 Alfred Nobel Drive, Hercules, ... Introduction , ... proteins within a variety of cell culture and ... new techniques that apply a sandwich antibody capture approach , ...
... , , , , AquaPure RNA Isolation ... , Method , ... ml cell lysis solution to an Oak Ridge centrifuge , tube (or ... (e.g., cerebrospinal fluid, plasma, saliva, serum, sputum, synovial fluid, , urine, whole ...
... , HaiYan Jiang a,e , Robert J. Hickey a-e, h ... W. Wills a, e , SuHua Han a,e , Timothy D. Tom a-g , YueTong ... a-e,+ , (a) Department of Pharmacology and Experimental Therapeutics , ... (d) Program in Toxicology (e) University of Maryland School ...
Other Biology Technology:Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 2Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 3Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 4Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 5Total RNA Isolation From 500 l Body Fluid 2Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 2Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 3Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 4Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 5Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 6Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 7Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 8Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A 9
(Date:12/14/2009)... The most comprehensive study to date of the proteins ... may provide important clues to how similar regeneration could ... School of Science at Indiana University-Purdue University Indianapolis and ... limbs of axolotls, a type of salamander that has ... level of amputation, with the hope that this knowledge ...
(Date:12/14/2009)... MODA Technology Partners, a global software ... product testing for the Pharmaceutical industry, today announced ... third generation mobile data acquisition platform. The latest ... automate their regulated manufacturing processes. ,, MODA ... Fully-Configurable Test Methods: Each test method ...
(Date:12/13/2009)... that are associated with the health of the human ... scientists from 63 centres in Europe and Australia sheds ... , The new findings provide hope for better treatment ... and asthma. In the past it has been difficult ... affect the health of the lung are not completely ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New genes for lung disease discovered 2Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 1Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 2Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 3Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 4Video 3A New National Campaign Launched to Raise Awareness of Osteoarthritis of the Knee and Encourage Patients to Get a Kick Out of Life 58261 5Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 1Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 2Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 3Video 3A Making Sense of Diabetes Video Contest Asks What Does Diabetes Taste Smell or Sound Like to You 3F 58259 4Symmetry Medical to Present at JMP Securities Healthcare Focus Conference 58257 1Symmetry Medical to Present at JMP Securities Healthcare Focus Conference 58257 2
... the first globally co-ordinated plan for the planet,s gravest ... the world this weekend, a new report sets out ... infectious diseases such as avian flu. , Ministers of ... prepare for, and respond to, the threat of avian ...
... cause of death in all cancer patients continues to be ... treatment in which chemicals are used to kill cells. ... on cancer cells reports that ingesting apigenin a naturally ... cancer cells, response to chemotherapy. , Xuan Liu , ...
... Health are testing an investigational treatment to learn if ... immediately help them breathe more easily. Destruction of lung ... overinflated with air that cannot escape. The holes, kept ... procedure, could relieve the hyperinflation of the lungs, allowing ...
Other Biology News:Avian flu threat: New approach needed 2How eating fruit and vegetables can improve cancer patients' response to chemotherapy 2National Jewish Health researchers evaluating treatment to help emphysema sufferers breathe easier 2
Request Info...
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
MOUSE ANTI SIMIAN VIRUS 5:FITC Immunogen: Simian virus 5...
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
Biology Products: